The role of FoxO transcription factors in normal and aberrant late lung development

F. Palumbo (Gießen , Germany)

Source: International Congress 2017 – Molecular pathways in lung development
Session: Molecular pathways in lung development
Session type: Poster Discussion
Number: 2088
Disease area: Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Palumbo (Gießen , Germany). The role of FoxO transcription factors in normal and aberrant late lung development. 2088

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Expression of C/EBP transcription factors in mouse lung development
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002

The role of miR-135b in normal and aberrant post-natal lung development
Source: International Congress 2017 – Molecular biology of normal and abnormal lung development
Year: 2017


HMGA2 mediated epigenetic regulation of Gata6 controls epithelial WNT signaling during lung development
Source: International Congress 2017 – Molecular biology of normal and abnormal lung development
Year: 2017

Reduced expression of the transcription factor KLF4 in COPD macrophages is associated with dysfunctional differentiation
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017

PP221 – EZH2-dependent transcriptional complex promotes aberrant epithelial remodelling after injury
Source: ERS Lung Science Conference 2021
Year: 2021

FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012

The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury
Source: ERS Lung Science Conference 2017
Year: 2017

Potential involvement of Egr1 (early growth response 1) gene in mediation of alveolarization and lung growth
Source: Annual Congress 2007 - Novel genetic markers in pathology
Year: 2007


Transcription factor FOXF1 induces cancer-associated fibroblast-like phenotype to promote lung cancer progression
Source: Annual Congress 2009 - Pathogenesis of lung cancer
Year: 2009



Late Breaking Abstract - The role of the transcription factor PU.1 in lung cancer
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020


miR-146a-5p plays an essential role in the aberrant epithelial–fibroblast cross-talk in COPD
Source: Eur Respir J, 49 (5) 1602538; 10.1183/13993003.02538-2016
Year: 2017



YI01 - Follistatin-like 1: a crucial factor in lung development and a novel regulator of airway remodelling
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Year: 2012

Depletion of STAT6 suppresses lung cancer progression through regulating M2-macrophage polarization
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

Epigenetic deregulated translation control of C/EBP-alpha leads to increased mesothelioma cell proliferation
Source: Annual Congress 2011 - Pleural and mediastinal malignancies: management and rare clinical cases
Year: 2011

The role of epithelial Pten in programmed cellular senescence during lung development
Source: International Congress 2018 – Molecular and cellular determinants of the developing lung
Year: 2018

Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis
Source: Eur Respir J 2015; 45: 116-128
Year: 2015



BMP-Smad1 target gene Wnt inhibitory factor 1 (WIF1) coordinates BMP and Wnt signaling activities in regulating lung development in vivo
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010

Inhibition of hypoxia-induced phenotype alterations through epithelial-mesenchymal transition (EMT) in lung cancer by gene modulation of phosphorylation sites in tumor suppressor PTEN
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011